Stephen Warman, MD
Otolaryngology/Facial Plastic Surgery · Forest Hills, NYNPI 1780642371
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $31,028 of the $49,626 with a category attached, or 62.5%. 18 manufacturers reported payments, led by Neurent Medical Limited at 42.6% of the total. 2025 is the largest year on record at $24,144, 8.4 times the $2,885 reported in 2019. Among otolaryngology/facial plastic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 587 payments — averaging $84.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurent Medical Limited$21K
- Aerin Medical Inc.$21K
- Stryker$4K
- Sanofi$1K
- Arrinex, Inc.$902
- Regeneron Healthcare Solutions, Inc.$662
- plus $1K from 12 others
What the payments were for
- Consulting fees$18,50037%
- Food & beverage$31,02863%
- Education$800%
- Gifts$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurent Medical Limited | 352 | $21,165 |
| Aerin Medical Inc. | 46 | $20,723 |
| Stryker | 55 | $3,577 |
| Sanofi | 38 | $1,217 |
| Arrinex, Inc. | 10 | $902 |
| Regeneron Healthcare Solutions, Inc. | 30 | $662 |
| GSK | 19 | $389 |
| Optinose US, Inc. | 14 | $326 |
| AbbVie(2 entities) | 8 | $217 |
| Acclarent, Inc | 1 | $88 |
| Hikma Pharmaceuticals USA | 4 | $82 |
| Intersect ENT, Inc. | 2 | $81 |
| AstraZeneca | 1 | $81 |
| Merz North America, Inc. | 2 | $27 |
| Alk-abello, Inc | 2 | $27 |
| Novartis | 1 | $22 |
| Merck | 1 | $20 |
| Xoran Technologies LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$19,887
- NEUROMARK Radiofrequency Console$5,426
- NEUROMARK Device$4,849
- NEUROMARK System$1,646
- RHINAER STYLUS$1,387
- NEUROMARK Radiofrequency Generator$1,069
- CLARIFIX$733
- DUPIXENT$658
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$526
- ENTELLUS - ENTELLUS MEDICAL SHAVER SYSTEM$498
- FIAGON NAVIGATION UNIT$462
- SHAVER SYSTEM$378
- SCOPIS ENT$171
- ENTELLUS - MINIFESS SURGICAL INSTRUMENT SETS$143
- ENTELLUS - MINIFESS MAXILLARY SEEKERS$135
- CONSUMABLES$133
- S-SERIES$117
- XPRESS ENT DILATION SYSTEM$115
- FOCESS HD WIRELESS CAMERA$114
- ENTELLUS - XPRESS ENT DILATION SYSTEM$113
How this compares
$49,626 in reported general payments places this provider in the 95th percentile of 48 otolaryngology/facial plastic surgery providers in New York.
See all otolaryngology/facial plastic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 175 | $4,931 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 37 | $3,747 |
| Fluocinolone Acetonide Oil | 119 | $3,370 |
| Ipratropium Bromide | 157 | $2,991 |
| RyaltrisOlopatadine Hcl/Mometasone | 13 | $2,807 |
| Azelastine Hcl | 122 | $1,937 |
| Fluticasone Propionate | 116 | $1,035 |
| Omeprazole | 129 | $667 |
| Clarithromycin | 20 | $401 |
| Meclizine Hcl | 35 | $382 |
| Mupirocin | 64 | $373 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 38 | $252 |
| Clindamycin Hcl | 28 | $251 |
| Famotidine | 41 | $244 |
| Levofloxacin | 39 | $149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USARyaltris | $82 | $2,80713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 48 otolaryngology/facial plastic surgery providers in New York.
Other otolaryngology/facial plastic surgery in Forest Hills
- Jennifer LevineNew York$454K
- Jason MocheNew York$439K
- Stacey SilversNew York$42K
- Dara LiottaNew York$17K
- Amar SuryadevaraSyracuse$11K
- Sean KennedyGlens Falls$10K
- Jordon GrubeAlbany$9K
- Gary SnyderPlainview$8K
- Eliot DanzigerLevittown$7K
- Matthew DicksonGlens Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.